The Effcacy of Zinc for Treatment of Chronic Prostatitis
Abstract: to investigate the
efficacy of zinc supplementation in chronic prostatitis treatment. Methods:
present randomized clinical trial was conducted on 120 patients with diagnosis
of chronic prostatitis (IIIA NIH) after preliminary evaluation and ruling out
other conditions. The study group received oral zinc sulfate 220 mg daily as capsule
without any other supplements. The control group received placebo. Subjects were
examined for NIH-CPSI scores every 4 weeks for 12 weeks. Results: 101 subjects
completed the study. There were no statistically signifcant differences in
scores and sub-scores of NIH-CPSI between groups before intervention. Decline
in the score and sub-scores were more prominent in case group after beginning of
the study; though the differences were not statistically signifcant.
Furthermore, the differences in total score and pain score at 12 weeks follow
was statistically signifcant (p=0.003 and p=0.02, respectively). Conclusion:
zinc supplements may beneft in management of patients with chronic prostatitis
NIH-IIIA. It can be attributable to anti-bacterial and immuno-modulatory
functions of organic zinc in the body.
Author: Davoud Goodarzi, Ali
Cyrus, Mohmoud R. Baghinia, Amir M. Kazemifar, M. Shirincar
Journal Code: jpkedokterangg130269
